ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Researchers Plan Collaborative Studies

February 27, 2004

Sondik Named Acting DCPC Deputy Director Sinks Leaving at End Of Month; Edwards Costlow Acting Ads

July 21, 1989

Carlson Named NCCN Chief Executive

September 28, 2012

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

November 22, 2013

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011

White House Says Upton Appointment Due In Two Weeks

July 29, 1977